Johnson & Johnson/JNJ
$154.64
0.35%-
1D1W1MYTD1YMAX
About Johnson & Johnson
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, and vision fields. These products are distributed to wholesalers, hospitals, and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.
Ticker
JNJ
Sector
Healthcare
Trading on
NYSE
Industry
Biotechnology & Drugs
CEO
Joaquin Duato
Employees
131,900
Headquarters
New brunswick, United States
Website
www.jnj.com
JNJ Metrics
BasicAdvanced
$372B
Market cap
10.17
P/E ratio
$15.21
EPS
0.54
Beta
$4.76
Dividend rate
3.21%
Dividend yield
Price and volume
Market cap
$372B
Beta
0.54278
52-week high
$175.97
52-week low
$143.13
Average daily volume
7.5M
Dividend rate
$4.76
Financial strength
Current ratio
1.17
Quick ratio
0.936
Long term debt to equity
35.821
Total debt to equity
48.032
Dividend payout ratio (TTM)
66.9%
Enterprise value to free cash flow
47.891
Management effectiveness
Return on assets (TTM)
9.28%
Return on equity (TTM)
24.23%
Return on investment (TTM)
13.19%
Valuation
Price to earnings (TTM)
10.168
Price to revenue (TTM)
4.345
Price to book
5.315
Price to free cash flow (TTM)
53.114
Five year average dividend yield
2.61%
Dividend yield (TTM)
3.08%
Forward dividend yield
3.21%
Growth
Revenue change (TTM)
10.57%
Earnings per share change (TTM)
69%
3-year revenue growth
1.03%
3-year earnings per share growth
-1.2%
3-year dividend per share growth
5.7%
What the Analysts think about JNJ
Analyst Ratings
Majority rating from 24 analysts.
Price Targets
Average projection from 22 analysts.
High $215.00
Low $155.00
$154.64
Current price
$172.72
Average price target
JNJ Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$21B
-0.06%
Net income
$3.3B
-19.61%
Profit margin
15.22%
-19.56%
JNJ Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.80
$2.66
$2.29
$2.71
-
Expected
$2.62
$2.52
$2.28
$2.64
$2.71
Surprise
7.02%
5.73%
0.4%
2.76%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Upcoming events
FAQs
What’s the current market cap for Johnson & Johnson stock?
Johnson & Johnson (JNJ) has a market cap of $372B as of May 20, 2024.
What is the P/E ratio for Johnson & Johnson stock?
The price to earnings (P/E) ratio for Johnson & Johnson (JNJ) stock is 10.17 as of May 20, 2024.
Does Johnson & Johnson stock pay dividends?
Yes, the Johnson & Johnson (JNJ) stock pays dividends to shareholders. As of May 20, 2024, the dividend rate is $4.76 and the yield is 3.21%. Johnson & Johnson has a payout ratio of 66.9% on a trailing twelve-month basis.
When is the next Johnson & Johnson dividend payment date?
The next Johnson & Johnson (JNJ) dividend payment is scheduled for June 04, 2024.
What is the beta indicator for Johnson & Johnson?
Johnson & Johnson (JNJ) has a beta rating of 0.54. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Johnson & Johnson stock price target?
The target price for Johnson & Johnson (JNJ) stock is $172.72, which is 11.69% above the current price of $154.64. This is an average based on projections from 22 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.
Buy or sell Johnson & Johnson stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.